{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:23:25Z","timestamp":1783981405729,"version":"3.55.0"},"reference-count":9,"publisher":"Japanese Society of Internal Medicine","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,10,1]]},"DOI":"10.2169\/internalmedicine.8123-21","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T22:11:28Z","timestamp":1628201488000},"page":"3167-3170","source":"Crossref","is-referenced-by-count":9,"title":["SARS-CoV-2-related Progressive Brain White Matter Lesion Associated with an Increased Cerebrospinal Fluid Level of IL-6"],"prefix":"10.2169","volume":"60","author":[{"given":"Yuwa","family":"Oka","sequence":"first","affiliation":[{"name":"Department of Neurology, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomokazu","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiro","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Respiratory Disease Center, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Inoue","sequence":"additional","affiliation":[{"name":"Respiratory Disease Center, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Marumo","sequence":"additional","affiliation":[{"name":"Respiratory Disease Center, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadayuki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bodro M, Compta Y, S\u00e1nchez-Valle R. Presentations and mechanisms of CNS disorders related to COVID-19. Neurol Neuroimmunol Neuroinflamm 8: e923, 2021.","DOI":"10.1212\/NXI.0000000000000923"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. New Engl J Med 382: 2268-2270, 2020.","DOI":"10.1056\/NEJMc2008597"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Amruta N, Chastain WH, Paz M, et al. SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders. Cytokine Growth Factor Rev 58: 1-15, 2021.","DOI":"10.1016\/j.cytogfr.2021.02.002"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bodro M, Compta Y, Llans\u00f3 L, et al. Increased CSF levels of IL-1B, IL-6, and ACE in SARS-CoV-2-associated encephalitis. Neurol Neuroimmunol Neuroinflamm 7: e821, 2020.","DOI":"10.1212\/NXI.0000000000000821"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395: 1033-1034, 2020.","DOI":"10.1016\/S0140-6736(20)30628-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kreye J, Reincke SM, Pr\u00fcss H. Do cross-reactive antibodies cause neuropathology in COVID-19? Nat Rev Immunol 20: 645-646, 2020.","DOI":"10.1038\/s41577-020-00458-y"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Novi G, Rossi T, Pedemonte E, et al. Acute disseminated encephalomyelitis after SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm 7: e797, 2020.","DOI":"10.1212\/NXI.0000000000000797"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 11: 995-998, 2020.","DOI":"10.1021\/acschemneuro.0c00122"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ranganathan C, Fusinski SD, Obeid IM, et al. Therapeutic plasma exchange for persistent encephalopathy associated with Covid-19. eNeurologicalSci 22: 100327, 2021.","DOI":"10.1016\/j.ensci.2021.100327"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/19\/60_8123-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T05:55:14Z","timestamp":1633154114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/19\/60_8123-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":9,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8123-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,1]]},"article-number":"8123-21"}}